Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Phenomenex Launches Innovative, Industry-Focused Websites

Published: Friday, February 22, 2013
Last Updated: Friday, February 22, 2013
Bookmark and Share
Company builds on award-winning web presence with new digital experience.

Phenomenex Inc. announces an entirely new "Smart Web" design, organized for the key industries the company serves. Redesigned from the ground up, the industry-specific gateways function as complete digital consultants, helping users find answers by providing customized content and newsletters along with product selection and method development tools.

Already recognized as an innovator in web design, Phenomenex has created the new industry sites to address overall user movement toward researching, purchasing and applying products completely with web tools. The digital experience is designed to anticipate customer needs and questions.
 
"Smart Web" industry-specific sites are now live for pharmaceutical, food and beverage, clinical research, environmental, forensic toxicology and fuels customers.

"We have customers across the globe, working at all hours, who are searching online for answers. We wanted to give them the same high level of support and service in the digital space that they have come to expect when working with us in person," explains Michael Garriques, Internet marketing manager at Phenomenex. "They want immediate information to help them quickly figure out which column is best for their application, purchase that column and then develop the most effective methods for their compounds. Our in-house web team has broken new ground and created an easy-to-use 'digital experience' designed to give customers the answers they need from anywhere at anytime."

In 2011, Phenomenex received the award for best biotechnology website in the Web Marketing Association's Web Award competition. The Phenomenex web tools are available across platforms and across languages including Chinese and Korean. The company has been regularly developing new web tools that enhance the user experience. Phenomenex's proprietary structure search capability, enhanced last year, enables researchers to find a method by simply drawing the chemical structure - something that is second nature to them. In addition to saving time, this approach is easy for researchers at all experience levels and, because chemical structures are universal throughout the world, it is equally convenient for users in all countries.

"Structure Search is a nice addition to your already excellent application search tools. Phenomenex has become my first web stop when searching for GC and LC applications in our lab. Kudos," commented Brandon Doss  of Algenol Biofuels.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Biomolecular Manufacturing ‘On-the-Go’
Wyss Institute team unveils a low-cost, portable method to manufacture biomolecules for a wide range of vaccines, other therapies as well as diagnostics.
Molecular Switch Aids Immune Therapy
Researchers identify strategy to maximise effectiveness of immune therapy through molecular switch controlling immune suppression.
Novavax RSV F Vaccine Fails Phase 3 Trial
Novavax announces topline RSV F Vaccine data from two clinical trials in older adults.
GSK’s Shingles Vaccine Candidate Shows High Efficacy
The vaccine candidate showed high efficacy against shingles and its complications in adults aged 70yrs+ in phase III study.
Eisai Establishes AiM Institute
The Andover innovative Medicines (AiM) Institute will develop innovative precision medicines for hard-to-treat conditions.
Antibodies that Target Holes in HIV's Defence Identified
Scientists suggest 'holes' in HIV sugar sheild can be targeted by antibodies.
Discovery Could Yield Improved Flu Vaccines
Researchers have discovered a type of immune antibody that can evolve to combat a number of infuenza virus strains.
First Accurate Simulation of a Virus Invading a Cell
For the first time, scientists know what happens to a virus’ shape when it invades a host cell.Understanding how the virus shape specifically changes could lead to more effective anti-viral therapies.
Developing a Vaccine for Sexually Transmitted and Insect-Borne Zika Infections
Prokarium announce the beginning of a programme to develop an oral vaccine against Zika infection.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!